HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Flurbiprofen: therapeutic alternative in nephritic colic].

Abstract
A double blind randomized study was conducted in 52 patients with renoureteric colic to compare the therapeutic efficacy of two analgesics given in a single intramuscular dose. Following the administration of 2 gm dipirone plus 20 mg hyoscine N-butylbromide (n = 26) or 150 mg flurbiprofen (n-26), the patients were assessed for pain intensity, relief and pain status for a period of one hour. Both treatments afforded a similar analgesic effect, with pain remitting in 76.9% of the cases. No significant differences were observed for the latency periods or degree of pain at 5, 10, 30 and 60 minutes following treatment. Additional analgesic therapy was required in 34.6% of the patients who received dipirone and 26.9% of the flurbiprofen group, the difference not being statistically significant. Overall both drugs were well tolerated and only local adverse effects were observed, pain being the most frequent.
AuthorsM Julián Mora, J Extramiana, F J Navarro, M Arrizabalaga, A Mañas, P González, M J Pérez, P Paniagua
JournalArchivos espanoles de urologia (Arch Esp Urol) Vol. 45 Issue 8 Pg. 773-7 (Oct 1992) ISSN: 0004-0614 [Print] Spain
Vernacular TitleFlurbiprofen: alternativa terapéutica en el dolor del cólico nefrítico.
PMID1466576 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Flurbiprofen
  • Dipyrone
  • Scopolamine
Topics
  • Adult
  • Aged
  • Colic (complications, drug therapy)
  • Dipyrone (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Flurbiprofen (therapeutic use)
  • Humans
  • Kidney Calculi (complications)
  • Kidney Diseases (drug therapy)
  • Male
  • Middle Aged
  • Scopolamine (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: